Search Results

Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.

• Authors : Proto MC; Department of Pharmacy, University of Salerno, Fisciano, 84084, Italy.; Fiore D

Subjects: Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/*pharmacology ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy

• Source: Scientific reports [Sci Rep] 2017 Sep 15; Vol. 7 (1), pp. 11678. Date of Electronic Publication: 2017 Sep 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

CB 1 antagonism increases excitatory synaptogenesis in a cortical spheroid model of fetal brain development.

• Authors : Papariello A; Department of Pharmacology and Toxicology, Brody School of Medicine at East Carolina University, Greenville, NC, 27834, USA.; Taylor D

Subjects: Brain/Brain/Brain/*physiology ; Cerebral Cortex/Cerebral Cortex/Cerebral Cortex/*physiology ; Fetus/Fetus/Fetus/*physiology

• Source: Scientific reports [Sci Rep] 2021 Apr 30; Vol. 11 (1), pp. 9356. Date of Electronic Publication: 2021 Apr 30.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.

• Authors : Mehrpouya-Bahrami P; Department of Pathology, Microbiology, and Immunology, School of Medicine, Columbia, SC, USA.; Chitrala KN

Subjects: Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/*pharmacology ; Gastrointestinal Microbiome/Gastrointestinal Microbiome/Gastrointestinal Microbiome/*drug effects ; Obesity/Obesity/Obesity/*drug therapy

• Source: Scientific reports [Sci Rep] 2017 Nov 15; Vol. 7 (1), pp. 15645. Date of Electronic Publication: 2017 Nov 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist snap-94847 in diet-induced obese mice

• Authors : Verty, Ana; Lockie, S.H.; Stefanidis, A.

• Source: International Journal of Obesity. February 1, 2013, Vol. 37 Issue 2, p279, 9 p.

Record details

CB1 antagonists for obesity--what lessons have we learned from rimonabant?

• Authors : Di Marzo, Vincenzo; Despres, Jean-Pierre

• Source: Nature Reviews Endocrinology. Nov, 2009, Vol. 5 Issue 11, p633, 6 p.

Record details

Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant

• Authors : Herling, A.W.; Kilp, S.; Juretschke, H.-P.

• Source: International Journal of Obesity. Sept, 2008, Vol. 32 Issue 9, p1363, 10 p.

Record details

Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats

• Authors : Kunz, I.; Meier, M.K.; Bourson, A.

• Source: International Journal of Obesity. May, 2008, Vol. 32 Issue 5, p863, 8 p.

Record details

Neuropsychiatric adverse effects signal the end of the line for rimonabant

• Authors : King, Alexandra

• Source: Nature Reviews Cardiology. November, 2010, Vol. 7 Issue 11, p602, 1 p.

Record details

Rimonabant adds appetizing choice to slim obesity market

• Authors : Wadman, Meredith

• Source: Nature Medicine. Jan, 2006, Vol. 12 Issue 1, p27, 1 p.

Record details

Deacylative transformations of ketones via aromatization-promoted C-C bond activation.

• Authors : Xu, Yan; Qi, Xiaotian; Zheng, Pengfei

• Source: Nature. March, 2019, Vol. 567 Issue 7748, p373, 6 p.

Record details